Assurance Infusion recalls hydromorphone 6mg/ml injection in 20mL syringes due to lack of sterility assurance. Affected lots: 12132019@9, expiring 12/22/2019.
Lack of sterility assurance.
Assurance Infusion is recalling hydromorphone 6mg/ml injection in 20mL syringes because they may not be sterile. This could lead to infections if used improperly.
The syringes lack sterility assurance, meaning they could be contaminated with bacteria. If used, this could cause infections in patients receiving the medication.
Patients using hydromorphone injections from Assurance Infusion. Healthcare providers administering these injections are most at risk.
Check for the lot number 12132019@9 on the syringe, which expires December 22, 2019. The product is hydromorphone 6mg/ml injection in a 20mL syringe.
Look for the lot number 12132019@9 on the syringe, which expires December 22, 2019.
The recall states there is a lack of sterility assurance, so it may not be safe to use.
The recall does not specify a remedy, so contact Assurance Infusion at (713) 533-8800 for guidance.
Check for the lot number 12132019@9 on the syringe, which expires December 22, 2019.
We’ve drafted a message you can send Assurance Infusion to request your refund or repair — edit it as you like.
Subject: Recall D-0747-2020 — Assurance Infusion Assurance Infusion Hello, I own a Assurance Infusion that is covered by recall D-0747-2020 from Assurance Infusion. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
